Tenax Therapeutics TENX

$TENX If LEVEL-2 is successful and FDA approval eventually follows, Tenax estimates 1,5B peak sales. You do the math

$TENX Back to $19!

$TENX Now it will be back to $1.88. It likes going up and down every day. Until we get the news, we are going to see this regularly. 🚀😊

$TENX I like it....

$TENX no se suelten!! cójanse fuerte!!

$TENX I just bought another one of those......fuck😂

$TENX has functioned as a wealth-destroying capital incinerator by repeatedly wiping out retail investor value to fund a pipeline of clinical dead ends. Over its decades-long history, the company has completely failed or abandoned four major drug programs, including Oxycyte in 2014, intravenous Levosimendan in 2017, TNX-201 in 2023, and oral Levosimendan, which catastrophically missed its Phase 3 endpoints in August 2026. To survive these sequential clinical failures and counter the heavy stock dilution required to fund them, management has executed five separate reverse stock splits since 2009, a 1-for-15, three consecutive 1-for-20s, and a massive 1-for-80 split in January 2024. So this really is a leap of faith. Understand the gamble.

$TENX hit that $2!